News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Nanosphere, Inc. to Present at the Credit Suisse 2013 Healthcare Conference


11/8/2013 9:24:39 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NORTHBROOK, IL--(Marketwired - November 08, 2013) - Nanosphere, Inc. (NASDAQ: NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that an overview of the company's business and commercial strategy will be given by Nanosphere's Chief Financial Officer Roger Moody at the Credit Suisse 2013 Healthcare Conference, being held at The Phoenician, Scottsdale in Scottsdale, Arizona from November 11-14, 2013. The Nanosphere presentation is on Wednesday, November 13 at 12:30 pm Eastern Time.

A live webcast of Nanosphere's presentation will be available at www.nanosphere.us.

About Nanosphere, Inc.
Nanosphere is enhancing medicine through targeted molecular diagnostics that result in earlier disease detection, optimal patient treatment and improved healthcare economics. The Company's versatile technology platform, the Verigene® System, enables clinicians to rapidly detect the most complex, costly and deadly infectious diseases through a low cost and simple-to-use multiplexed diagnostic test. The combination of this innovative technology and Nanosphere's customer-driven solutions keeps commitment to the patient at the forefront of its business. Nanosphere is based in Northbrook, IL. Additional information is available at http://www.nanosphere.us.

Except for historical information, the matters discussed in this press release are "forward-looking statements" and are subject to risks and uncertainties. Actual results could differ materially from these forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the following: (i) Nanosphere's ability to develop commercially viable products; (ii) Nanosphere's ability to achieve profitability; (iii) Nanosphere's ability to produce and market its products; (iv) Nanosphere's ability to obtain regulatory approval of its products; (v) Nanosphere's ability to protect its intellectual property; (vi) competition and alternative technologies; and (vii) Nanosphere's ability to obtain additional financing to support its operations. Additional risks are discussed in the Company's current filings with the Securities and Exchange Commission. Although the Company believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. The forward-looking statements are made as of the date of this press release, and we undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.


Investor Contacts
Roger Moody
Chief Financial Officer
847-400-9021
rmoody@nanosphere.us

Michael Rice
LifeSci Advisors
646-597-6979
mrice@lifesciadvisors.com



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES